Introduction: Pancreatic cancer is the tenth most common cancer in The UK. Over 33% of patients
have distant metastasis at diagnosis [1]. NICE guideline [NG85] states that patients
with pancreatic cancer having surgery should undergo pre-operative FDG-PET/CT (PET-CT)
for staging [2]. A study by Farma et al showed 11% of patients with pancreatic cancer
had a change to their management as PET-CT detected metastasis not identified by standard
protocols [3]. This audit assessed if patients were undergoing a preoperative PET-CT
as per NICE guidelines.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Surgical OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
18.
Identification
Copyright
© 2022 Published by Elsevier Inc.
